The year is coming to a rapid close, and it\u2019s a great time to reflect on the accomplishments and inspiration of the past year. We\u2019re really proud of the content we\u2019ve created here at ASweetLife, bringing breaking news, recipes, lifestyle pieces, and bits of humor and insight to the diabetes community every week. Which is why we\u2019ve leapt ever-so-casually into the Wayback Machine to take a spin through some of our most popular diabetes stories from this year. Is your favorite on the list?<\/p>\n
Actress and Diabetes Advocate Mary Tyler Moore Dies at 80<\/strong><\/a>: \u201cFor years, the first voice that greeted us on the JDRF phone system was that of Mary Tyler Moore. As it should have been. Ms. Moore was, after all, the heart, soul and lifeblood of the JDRF. It is not an exaggeration to say her willingness to share not just that voice, but that smile, that honesty, and that star-power pushed the diabetes treatment and research landscape to the place it is today.\u201d In 2017, we said goodbye to one of the most prominent, dedicated, and inspiring advocates for people with diabetes \u2013 Mary Tyler Moore. Moira McCarthy\u2019s moving piece on Moore\u2019s passing and her lasting influence on the diabetes community<\/a> is a must-read.<\/p>\n The Never-Relaxed Parent of A Child With Diabetes<\/strong><\/a>: \u201cAs I held my son and waited for him to \u201ccome back\u201d\u2014and yes, through the years I envision that during hypoglycemic episodes he does go someplace else, where his arms and legs are tied to bricks, where he seems to slip away from me\u2014I realized that I\u2019ve gone somewhere, too.\u201d Annie Stoltie writes about what it\u2019s like to parent a young child with type 1 diabetes and how their lives have changed since her son\u2019s diagnosis.<\/p>\n I Know About Needles<\/strong><\/a>: Sarah Vedomske, one of A Sweet Life\u2019s newest writers, made her debut with this beautiful essay about the intimacy of needles in her diabetes life. \u201cI know about the orange-capped syringes, how to hold the barrel up to the light, tap the tiny air bubbles to the top, push the plunger, squeeze them out. I know, from being a perfectionist, that sometimes no amount of flicking and tapping and cursing and squinting will release that last miniscule burst of air. I know it is not recommended to reuse these, but I also know that I\u2019ve reused a syringe to the point of all numbers\u2014the measurements\u2014being worn off, to an unmarked barrel, eyeballing my dose.\u201d<\/p>\n Succeeding with Diabetes on a Vegan Diet<\/strong><\/a>: We looked at veganism and diabetes again in 2017, interviewing Lee Ann Thill for her perspectives. \u201cBut veganism isn\u2019t entirely about diet, for Lee Ann. There\u2019s a bigger picture in play, and one that directly touches her experiences with diabetes. \u2018Being vegan has made me more curious about power \u2013 who has it, who doesn\u2019t, forces maintaining those dynamics \u2013 ways to alter power dynamics, and more critical of how my actions can better reflect my personal values, notably, fairness, empathy, knowledge, and creativity.\u2019\u201d<\/p>\n In Defense of the Unicorn Frappuccino<\/strong><\/a>: ASweetLife\u2019s editor-in-chief, Jessica Apple, dives headfirst into the controversy over Starbucks\u2019 unicorn frappuccino, which was unleashed last Spring. \u201cThe people of the internet have been making jokes about the Unicorn Frappuccino, calling it diabetes-in-a-cup. And everyone knows that unicorns don\u2019t give you diabetes, so the joke isn\u2019t funny. And what also isn\u2019t funny is that the one responsible for the type 2 diabetes crisis in America is not a horny horse or any single food\/beverage corporation, but the U.S. government.\u201d<\/p>\n The Promise of Generic Insulin<\/strong><\/a>: \u201cIn between working towards a PhD in computer science at U.C. Davis, Di Franco is working to understand enough about producing insulin in a simpler and cheaper way to establish a protocol for enabling almost any business entity to produce insulin. Without the enormous R & D costs that Big Pharma likes to point to when they speak to costs, the Open Insulin Project hopes to open the market to cheaper insulin and happier people with diabetes.\u201d Larissa Zimberoff takes a look at the progress made towards generic insulin.<\/p>\n Solving the Jackie Robinson Diabetes Mystery<\/strong><\/a>: \u201cToday, exactly two years before the 100th anniversary of Robinson\u2019s birth, it\u2019s not common knowledge that he lived with diabetes. In fact, his diabetes remains so shrouded in mystery that there isn\u2019t even a clear consensus about which type he had.\u201d Did you know that baseball great and first African American to play in the major leagues, Jackie Robinson, had diabetes? Alex O\u2019Meara takes a look at this mystery.<\/p>\n New Theory About the Cause of Type 1 Diabetes<\/strong><\/a>: What\u2019s beta than a new theory to noodle around about the origin of type 1 diabetes? The ASweetLife team checked out this news story in depth. \u201cIn order to gain a better understanding of why the immune system attacks the body\u2019s own source of insulin \u2014 the pancreatic beta cells in the islets of Langerhans \u2014 the team took some clues from cancer molecules that are targeted by the immune system after successful treatment of the cancer with immunotherapy.\u201d<\/p>\n Girl With Diabetes and Insulin Allergy to Receive Pancreas Transplant<\/strong><\/a>: What do you do when you have diabetes and you\u2019re allergic<\/em> to insulin? Columnist Moira McCarthy covered this story for ASweetLife. \u201cA 12-year old South Carolina girl with Type 1 diabetes and what her parents describe as an intense allergy to insulin therapy is set to undergo a rarely performed whole pancreas transplant at the University of Minnesota.\u201d<\/p>\n 7 Diabetes Technology Updates for 2018<\/strong><\/a>: We can\u2019t close out 2017 without looking into 2018, taking a peek at what\u2019s next in diabetes technology. Christopher Snider closes out our list with his look at what to keep an eye on next year. \u201cWhen I think about the scope and potential of diabetes technology, it\u2019s more than just a specific product or products that may come to market. So here\u2019s a glimpse at some of the companies and movements that I am going to pay close attention to next year as diabetes technology looks to take another major step forward in 2018.\u201d<\/p>\n But these aren\u2019t all the posts we loved in 2017. Take a look through our recipes<\/a>, or what\u2019s new in diabetes advocacy<\/a>, or at some personal stories from PWD like you<\/a>. And thanks. A big thanks for reading ASweetLife in 2017. We\u2019re excited to bring you more diabetes information and inspiration in 2018!<\/p>\n","protected":false},"excerpt":{"rendered":" …<\/p>\n","protected":false},"author":131,"featured_media":48233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1428],"tags":[],"yoast_head":"\n